US Broker Ratings

Teladoc Health, Inc. (TDOC) Stock Analysis: Exploring a Potential 43.60% Upside in Virtual Healthcare

In the ever-evolving landscape of healthcare, Teladoc Health, Inc. (NYSE: TDOC) stands as a prominent player, offering a comprehensive suite of virtual healthcare services. With a market capitalization of $1.11..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Strong Buy Ratings Signal Potential 17% Upside

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a biotechnology company at the forefront of peptide therapeutics, is garnering significant attention from investors and analysts alike. With a market capitalization of $5.13 billion,..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Healthcare Innovation Amidst Market Challenges

10x Genomics, Inc. (NASDAQ: TXG), a pioneering force within the healthcare sector, has carved a niche in the health information services industry. With its headquarters in Pleasanton, California, the company..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Challenges in the Healthcare Sector

For individual investors eyeing opportunities in the healthcare sector, BGM Group Ltd. (BGM) presents a complex yet intriguing case. Based in Chengdu, China, BGM operates within the intricate domain of..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 21% Potential Upside for Investors

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a distinguished player in the healthcare sector, is capturing investor attention with its unique blend of generic and proprietary injectable, inhalation, and intranasal products. Operating..

Pacira BioSciences, Inc. (PCRX) Investor Outlook: Exploring a 55% Potential Upside

Pacira BioSciences, Inc. (NASDAQ: PCRX), a prominent player in the healthcare sector specializing in non-opioid pain management solutions, presents an intriguing opportunity for investors. With a market capitalization of $824.29..

Merus N.V. (MRUS) Stock Analysis: Biotechnology Innovator with 7.78% Upside Potential

Merus N.V. (NASDAQ: MRUS), a Netherlands-based clinical-stage biotechnology company, is making waves in the healthcare sector with its promising pipeline of bispecific antibody candidates. With a market capitalization of $6.83..

Concentra Group Holdings (CON): Healthcare’s Hidden Gem with a 31.92% Potential Upside

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a prominent player in the healthcare sector, has steadily carved a niche in the medical care facilities industry. Headquartered in Addison, Texas, Concentra..

LifeStance Health Group, Inc. (LFST) Stock Analysis: A 22.61% Upside in the Healthcare Sector

LifeStance Health Group, Inc. (LFST) has been capturing attention in the healthcare sector, particularly among investors keen on the medical care facilities industry. Headquartered in Scottsdale, Arizona, LifeStance Health Group..

ARS Pharmaceuticals, Inc. (SPRY) Investor Outlook: Analyzing the 171% Upside Potential for This Biotech Stock

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) has captured the attention of investors within the healthcare sector, boasting a significant market cap of $1.05 billion and a promising upside potential of 171.24%...

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Evaluating Growth Potential Amidst Market Dynamics

Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider in the healthcare sector, specializes in neonatal and maternal-fetal care services across the United States. With a market capitalization of $1.9..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A Compelling Growth Story with 40% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC), a burgeoning player in the medical devices sector, is drawing significant attention from investors seeking opportunities in the healthcare space. With a market capitalization of..

Premier, Inc. (PINC) Investor Outlook: Navigating the 2.97% Dividend Yield Amidst Revenue Decline

Premier, Inc. (NASDAQ: PINC), a prominent player in the healthcare sector, specializes in health information services in the United States. With a market capitalization of $2.34 billion, Premier operates as..

Guardian Pharmacy Services, Inc (GRDN): Investor Outlook with 29% Upside Potential

Guardian Pharmacy Services, Inc (NASDAQ: GRDN) is capturing investor attention with its remarkable potential upside of nearly 29.49%, according to analyst ratings. As a prominent player in the healthcare sector,..

ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: Assessing 18% Potential Upside Amid Strategic Advancements

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology sector, continues to capture investor interest with its strategic focus on developing treatments for central nervous system (CNS) disorders..

Vericel Corporation (VCEL) Stock Analysis: Unpacking a 47% Potential Upside in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL) stands out in the biotechnology industry with a compelling narrative centered around innovative cellular therapies and specialty biologic products. Headquartered in Cambridge, Massachusetts, Vericel is carving..

Mirum Pharmaceuticals, Inc. (MIRM) Investor Outlook: Robust Buy Ratings Signal Potential Upside

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) stands out in the biotechnology sector, focusing on the development of therapies for rare and orphan diseases. With a market capitalization of $4.71 billion, this..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Analyzing a Promising 114% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a prominent player in the biotechnology sector focusing on innovative eye care solutions, presents an intriguing opportunity for investors. With its current market cap standing..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A 38.87% Potential Upside in the Biotech Sector

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a prominent player in the biotechnology sector, offers an exciting opportunity for investors eager to explore the healthcare industry’s potential for innovation and growth. Headquartered..

Metsera, Inc. (MTSR) Stock Analysis: Navigating the Biotech Waters with a -19.15% Potential Downside

Metsera, Inc. (MTSR), a clinical-stage biotechnology company, is making waves in the healthcare sector with its pioneering approach to addressing obesity and related disorders. Based in New York and now..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds